IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RA Capital Management, L.P.

Q4 2017 Holdings

Filed 2018-02-14 | 27 holdings | $263.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$223.6M5,580,69084.8%
Biocryst Pharmaceuticals(BCRX)COM09058V103$34.3M6,984,69213.0%
Argenx SE(ARGX)SPONSORED ADR04016X101$4.8M75,8161.8%
Wave Life Sciences LTD(WVE)SHSY95308105$263.7K7,512,0490.1%
Avexis IncCOM05366U100$129.6K1,171,2780.0%
Sage Therapeutics Inc(SG7)COM78667J108$75.0K455,1730.0%
Inflarx NV(IFRX)COMN44821101$60.3K2,876,0800.0%
Biohaven Pharmactl Hldg Co LTD(BHVN)COMG11196105$53.9K1,997,2780.0%
Zogenix IncCOM NEW98978L204$45.9K1,145,2680.0%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$44.8K4,965,5130.0%
Kala Pharmaceuticals IncCOM483119103$39.1K2,113,2360.0%
Myovant Sciences LTDCOMG637AM102$35.8K2,830,4550.0%
Scpharmaceuticals Inc(SCPH)COM810648105$34.5K2,857,1430.0%
Kadmon Hldgs Inc(KDMN)COM48283N106$22.7K6,269,3420.0%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$19.5K900,0000.0%
Spero Therapeutics Inc(SPRO)COM84833T103$14.4K1,225,6470.0%
Endocyte IncCOM29269A102$14.4K3,364,6480.0%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$14.1K5,062,7590.0%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$14.1K1,441,0700.0%
RA Pharmaceuticals IncCOM74933V108$11.5K1,351,8080.0%
Sunesis Pharmaceuticals IncCOM PAR867328700$11.4K3,096,8400.0%
Clementia Pharmaceuticals Inc COM NPVCOM185575107$11.1K585,4030.0%
Krystal Biotech Inc(KRYS)COM501147102$7.4K700,0000.0%
G1 Therapeutics Inc(GTHXEUR)COM3621LQ109$3.2K159,7800.0%
Proteon Therapeutics IncCOM74371L109$2.5K1,337,4620.0%
Chiasma Inc(CHMA)COM16706W102$2.0K1,176,8060.0%
Achillion Pharmaceuticals Inc(ACHNEUR)COM00448Q201$1.7K585,8900.0%